TAOX TAO Synergies Inc.
Healthcare$4.55+0.00%OpenMarket Cap: $15.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.30
P/S
21.64
EV/EBITDA
-1.23
DCF Value
$2.55
FCF Yield
-40.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.9%
Operating Margin
-1430.8%
Net Margin
-3615.4%
ROE
-120.3%
ROA
-80.1%
ROIC
-32.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $388.8K | 99.8% | $-1.2M | $4.3M | $— | — |
| Q4 null | $91.7K | 100.0% | $-3.8M | $-7.7M | $— | — |
| FY null | $299.1K | 100.0% | $-9.0M | $-28.7M | $— | — |
| Q3 null | $203.4K | 100.0% | $-1.8M | $-3.9M | $— | — |
| Q2 null | $4.0K | 100.0% | $-3.0M | $-17.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.1M | $385.2K | $— | — |
| Q4 null | $0.00 | NaN% | $-2.2M | $-5.5M | $— | — |
| FY null | $0.00 | NaN% | $0.00 | $-12.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.4M | $-5.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.6M | $-1.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.7M | $-206.7K | $— | — |
| FY null | $0.00 | NaN% | $0.00 | $-6.0M | $— | — |